UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials

BMJ, 2010-09, Vol.341 (7773), p.c4543-c4543

International edition, 2010

Volltextzugriff (PDF)

Screening for prostate cancer

Cochrane database of systematic reviews, 2013-01, Vol.2013 (1), p.CD004720-CD004720

2013

Volltextzugriff (PDF)

Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenous

Cancer, 2023-12, Vol.129 (24), p.3894-3904

2023

Volltextzugriff (PDF)

Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study

BMJ, 2009-06, Vol.338 (7710), p.b2307-b2307

International edition, 2009

Volltextzugriff (PDF)

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

The Journal of urology, 2023-07, Vol.210 (1), p.46-53

2023

Volltextzugriff (PDF)

A Proposed Brain-, Spine-, and Mental- Health Screening Methodology (NEUROSCREEN) for Healthcare Systems: Position of the Society for Brain Mapping and Therapeutics

Journal of Alzheimer's disease, 2022-01, Vol.86 (1), p.21-42

2022

Volltextzugriff (PDF)

Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2018-03, Vol.319 (9), p.883

2018

Volltextzugriff (PDF)

Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis

BMJ (Online), 2018-09, Vol.362, p.k3519

2018

Volltextzugriff (PDF)

National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening

Journal of clinical oncology, 2015-08, Vol.33 (22), p.2416-2423

2015

Volltextzugriff (PDF)

Human primary liver cancer-derived organoid cultures for disease modeling and drug screening

Nature Medicine, 2017-12, Vol.23 (12), p.1424-1435

2017

Volltextzugriff (PDF)

Extended follow‐up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial

BJU international, 2019-05, Vol.123 (5), p.854-860

2019

Volltextzugriff (PDF)

Absolute lung cancer risk increases among individuals with >15 quit‐years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines

Cancer, 2024-01, Vol.130 (2), p.201-215

2024

Volltextzugriff (PDF)

Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer

The Journal of urology, 2020-04, Vol.203 (4), p.706-712

2020

Volltextzugriff (PDF)

Assessment of prostate‐specific antigen screening: an evidence‐based report by the German Institute for Quality and Efficiency in Health Care

BJU international, 2022-03, Vol.129 (3), p.280-289

2022

Volltextzugriff (PDF)

Prostate Cancer Screening

The Medical clinics of North America, 2018-03, Vol.102 (2), p.199-214

Catalona, William J.

2018

Volltextzugriff (PDF)

Extended mortality results for prostate cancer screening in the PLCO trial with median follow‐up of 15 years

Cancer, 2017-02, Vol.123 (4), p.592-599

2017

Volltextzugriff (PDF)

A Pragmatic Approach to Prostate Cancer Screening

JAMA : the journal of the American Medical Association, 2024-05, Vol.331 (17), p.1448

2024

Volltextzugriff (PDF)

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

Annals of internal medicine, 2008-08, Vol.149 (3), p.185

U.S. Preventive Services Task Force

2008

Volltextzugriff (PDF)

Sexual risk characteristics, social vulnerability, and anal cancer screening uptake among men living with HIV in the deep south

AIDS care, 2024-06, Vol.36 (6), p.762-770

2024

Volltextzugriff (PDF)

The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate‐specific Antigen‐era

International journal of cancer, 2015-12, Vol.137 (12), p.2795-2802

2015

Volltextzugriff (PDF)

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios

Cancer medicine (Malden, MA), 2020-10, Vol.9 (20), p.7742-7750

2020

Volltextzugriff (PDF)

Modelling the impact of the coronavirus pandemic on bowel cancer screening outcomes in England: A decision analysis to prepare for future screening disruption

Preventive medicine, 2022-07, Vol.160, p.107076-107076, Article 107076

2022

Volltextzugriff (PDF)

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

BMJ (Online), 2018-09, Vol.362, p.k3581

2018

Volltextzugriff (PDF)

A nanodroplet cell processing platform facilitating drug synergy evaluations for anti-cancer treatments

Scientific reports, 2019-07, Vol.9 (1), p.10120-9, Article 10120

2019

Volltextzugriff (PDF)

1 – 25 von 21.028

Suche als RSS-Feed

Aktive Filter

SprachePolnisch

ThemaFemale

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19.402)
Mit Volltextzugriff
(16.068)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(17.294)
Life Sciences & Biomedicine
(16.613)
Humans
(16.509)
Biological And Medical Sciences
(8.434)
Medical Sciences
(8.283)
Middle Aged
(6.295)
Animals
(6.294)
Adult
(5.240)
Endocrinopathies
(5.219)
Diabetes. Impaired Glucose Tolerance
(5.195)
Endocrine Pancreas. Apud Cells
(5.195)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(5.191)
Aged
(4.463)
Mass Screening
(3.774)
Rats
(3.213)
Endocrinology & Metabolism
(3.147)
Prostatic Neoplasms - Diagnosis
(3.049)
Medical Screening
(2.962)
Prostate Cancer
(2.942)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes
(1.106)
Diabetologia
(596)
Plos One
(374)
Metabolism, Clinical And Experimental
(280)
The Journal Of Urology
(273)
European Urology
(210)
Bmj
(200)
European Journal Of Pharmacology
(196)
Bju International
(193)
Urology
(164)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials

Screening for prostate cancer

Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenous

Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

A Proposed Brain-, Spine-, and Mental- Health Screening Methodology (NEUROSCREEN) for Healthcare Systems: Position of the Society for Brain Mapping and Therapeutics

Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial

Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis

National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening

Human primary liver cancer-derived organoid cultures for disease modeling and drug screening

Extended follow‐up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial

Absolute lung cancer risk increases among individuals with >15 quit‐years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines

Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer

Assessment of prostate‐specific antigen screening: an evidence‐based report by the German Institute for Quality and Efficiency in Health Care

Prostate Cancer Screening

The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening

Extended mortality results for prostate cancer screening in the PLCO trial with median follow‐up of 15 years

A Pragmatic Approach to Prostate Cancer Screening

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement

Sexual risk characteristics, social vulnerability, and anal cancer screening uptake among men living with HIV in the deep south

The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate‐specific Antigen‐era

Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios

Modelling the impact of the coronavirus pandemic on bowel cancer screening outcomes in England: A decision analysis to prepare for future screening disruption

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

A nanodroplet cell processing platform facilitating drug synergy evaluations for anti-cancer treatments

Aktive Filter

Suchergebnisse filtern